Navigation Links
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Date:11/5/2009

ombination with oxaliplatin-based chemotherapy, including known events such as rash, diarrhea and hypomagnesemia. Vectibix-related grade 3 infusion reactions were reported for two patients (less than 1 percent).

Originally designed to compare the treatment effect in the overall population, the study was amended to analyze outcomes with respect to the presence or absence of activating mutations in KRAS in the tumor itself. Tumor KRAS status was ascertained in more than 90 percent of the 1,183 patients enrolled in the trial.

Available results from the trial were presented earlier this year at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany showing that Vectibix significantly improved median progression-free survival by 1.6 months (9.6 versus 8.0 months for patients treated with FOLFOX alone, in patients with KRAS wild-type mCRC (primary endpoint). Further, the addition of Vectibix to chemotherapy also improved response rate in the KRAS wild-type patient population as measured by blinded central review (55 percent versus 48 percent in the FOLFOX only arm).

The data for the 203 study has been submitted for consideration of presentation at the American Society of Clinical Oncology - The Gastrointestinal Cancers Symposium Meeting for 2010.

Study Design

Patients enrolled in the "203" or PRIME trial (Panitumumab Randomized trial in combination with chemotherapy for Metastatic colorectal cancer to determine Efficacy) were randomized to receive either 6.0 mg/kg of Vectibix and FOLFOX4 once every two weeks (Q2W) or FOLFOX4 alone Q2W. The primary endpoint of the study is progression-free survival by KRAS status and secondary endpoints include overall survival, objective response rate, time to progression, duration of response and safety.

About KRAS

Results from studies performed over the last twenty-five y
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Call for Applications: The Amgen Award for Science Teaching Excellence
2. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
3. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
4. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
5. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
6. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
7. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
8. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
9. Medarex to Receive Milestone Payment from Amgen
10. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
11. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... and PHOENIX , Aug. 20, ... bring cutting-edge next-generation sequencing and proteomic diagnostics and ... announced a collaboration with TESARO, Inc.  Paradigm will ... tissue samples from clinical trials to better predict ... TESARO,s TSR-011.  This may lead to more successful clinical ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: The Market ... http://www.reportlinker.com/p02051938/The-Market-for-Medical-Devices-in-EMEA .html The European, Middle Eastern and ... medical devices. As part of its coverage, this ... concentrates on the EMEA medical device markets and ...
(Date:8/20/2014)... 2014  Quantum Materials Corporation (OTCQB:QTMM) today announced ... families from Bayer Technology Services GmbH, the global technological ... of Leverkusen, Germany . ... property protection for advances Quantum Materials ... manufacturing. In addition, the Bayer patents cover volume ...
Breaking Medicine Technology:Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 Ticket Down ... Championship tickets in NYC. In just a week, the ... Jean King Tennis Center. The event was originally founded in 1881 ... event, Rafael Nadal was forced to withdrawal from the event because ... 2014 women’s tournament and will return to New York City with ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. ... saved a group of rhesus monkeys from deadly Marburg virus, ... to 90 percent of those it infects, researchers report. ... Marburg virus, even when it was given three days after ... journal Science Translational Medicine . This is the ...
(Date:8/20/2014)... the immune system is defective in people suffering from irritable ... ongoing issues with pain. , The research the first ... to explain why some painkillers may not offer satisfactory relief ... 10% of the community. There are different forms of ... often has the greatest impact on sufferers, quality of life. ...
(Date:8/20/2014)... York, NY (PRWEB) August 20, 2014 ... filed on behalf of women who were allegedly injured ... move forward in New Jersey’s Bergen County Superior Court, ... Order issued on August 15, 2014, the Court has ... files for Mirena lawsuits that are part of the ...
(Date:8/20/2014)... (HealthDay News) -- Loss of brain cells that act ... seniors have trouble falling and staying asleep, a new ... be especially severe and often results in nighttime confusion ... analyzed data from the Rush Memory and Aging Project, ... 65 and are being followed until death, at which ...
Breaking Medicine News(10 mins):Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 3Health News:Pain treatments less effective for those with irritable bowel 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2
... Local residents show America how they ,Think About Their Drink, ST. LOUIS, ... prize winner of the Think About ... The Maples family entered the photo contest by submitting a ... As part of a ...
... in Bangkok, will help bring enterprise-class health information system ... ... BANGKOK, Thailand, Oct. 29 Building on a,worldwide commitment to ... software, intellectual property and,other assets from Global Care Solutions (GCS), ...
... the most devastating spinal injuries - typically those caused ... fractures of the spine are being developed and tested ... of Leeds and Queens University Belfast. The team has ... Physical Sciences Research Council (EPSRC) to develop and examine ...
... Oregon Health & Science University Cancer Institute researchers ... stomachs rather than their backs is a better method ... therapies, being able to reproduce ,the positioning of the ... , It was a surprising finding, according to according ...
... Million Americans Suffer From Food Allergies and Numbers are,Climbing; More Children ... ... of Children, Hoping to Keep Allergy From ... Doc, NEW YORK, Oct. 28 Today about 11 million ...
... safety, proper use , SUNDAY, Oct. 28 (HealthDay News) -- ... best use of household cleaners and disinfectants from the Soap ... Fact Sheet outlines the safe, proper use of surface ... linger and the types of products available for consumer and ...
Cached Medicine News:Health News:MilkPEP: St. Louis Family Wins Nationwide got milk? Contest 2Health News:MilkPEP: St. Louis Family Wins Nationwide got milk? Contest 3Health News:Microsoft to Acquire Innovative Healthcare Technology and Assets From Global Care Solutions 2Health News:Microsoft to Acquire Innovative Healthcare Technology and Assets From Global Care Solutions 3Health News:Engineers developing new cements to heal spinal fractures 2Health News:Positioning pelvic cancer patients on stomachs for radiation yields better results 2Health News:NEWSWEEK: Cover: Kids and the Growing Food Allergy Threat 2Health News:NEWSWEEK: Cover: Kids and the Growing Food Allergy Threat 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: